SEEK Group has established a strong portfolio of assets. Its commercialisation strategy is to spin out companies when they reach a certain stage of development and to access external funding. The first spin out was the consumer healthcare company, infirst HEALTHCARE, which is commercialising innovative treatments for cough/cold, inflammatory pain, wound healing and gastric irritations. The second spin out was the clinics operation, Health Clinics Limited offers treatments for cancer. The third spin out was ValiSEEK Ltd developing old medicines with a new label for cancer. The fourth spinout has been Imutex. Further details on the portfolio are below.